Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07398287 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease

Name: Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease — clinical trial record (NCT07398287)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Ment-ILD

StatusRecruiting

PhasePhase 2

SponsorRegion Skane

Started2026-04-13

View on ClinicalTrials.gov ↗

Amendment history

2026-04-23

Study Status, Contacts/Locations v1

Recruitment opened

Start dateestimated 2026-02-15→confirmed 2026-04-13

Study sitesdetails revised at 2 of 2 sites

2026-02-04

Original filing

Region Skane

146 trials monitored

See 5 trials at risk

The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).

Trial Details

NCT Number	NCT07398287
Lead Sponsor	Region Skane Collaborators: Blekinge Institute of Technology, Blekingesjukhuset, Karlskrona, Lund University
Conditions	Interstitial Lung Disease (ILD)
Enrollment	20 participants
Start Date	2026-04-13
Primary Completion	2027-02 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-04-24